Translational Research in Culture: AADAC, Diabetes, and Cardiovascular Disease.
Journal
Cell stem cell
ISSN: 1875-9777
Titre abrégé: Cell Stem Cell
Pays: United States
ID NLM: 101311472
Informations de publication
Date de publication:
02 07 2020
02 07 2020
Historique:
entrez:
4
7
2020
pubmed:
4
7
2020
medline:
25
2
2021
Statut:
ppublish
Résumé
Many type 2 diabetes patients develop cardiovascular disease (CVD) while some are protected. Toyohara et al. (2020) find that elevated arylacetamide deacetylase (AADAC) expression in vascular smooth muscle cells (dVSMCs) differentiated from patient-derived induced pluripotent stem cells is associated with cardioprotection. AADAC overexpression alters multiple dVSMC properties and decreases murine CVD.
Identifiants
pubmed: 32619519
pii: S1934-5909(20)30279-4
doi: 10.1016/j.stem.2020.06.012
pii:
doi:
Substances chimiques
AADAC protein, human
EC 3.1.1.-
Carboxylic Ester Hydrolases
EC 3.1.1.-
Types de publication
Journal Article
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
6-7Commentaires et corrections
Type : CommentOn
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.